BiOasis Technologies Debt To Equity vs. Price To Sales

BIOAF Stock  USD 0.0001  0.00  0.00%   
Based on BiOasis Technologies' profitability indicators, biOasis Technologies may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess BiOasis Technologies' ability to earn profits and add value for shareholders.
For BiOasis Technologies profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BiOasis Technologies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well biOasis Technologies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BiOasis Technologies's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of biOasis Technologies over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between BiOasis Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if BiOasis Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiOasis Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

biOasis Technologies Price To Sales vs. Debt To Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BiOasis Technologies's current stock value. Our valuation model uses many indicators to compare BiOasis Technologies value to that of its competitors to determine the firm's financial worth.
biOasis Technologies is rated fourth in debt to equity category among its peers. It is rated second in price to sales category among its peers fabricating about  85.55  of Price To Sales per Debt To Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BiOasis Technologies' earnings, one of the primary drivers of an investment's value.

BiOasis Price To Sales vs. Debt To Equity

Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

BiOasis Technologies

D/E

 = 

Total Debt

Total Equity

 = 
0.31 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

BiOasis Technologies

P/S

 = 

MV Per Share

Revenue Per Share

 = 
26.52 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

BiOasis Price To Sales Comparison

BiOasis Technologies is currently under evaluation in price to sales category among its peers.

BiOasis Technologies Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BiOasis Technologies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BiOasis Technologies will eventually generate negative long term returns. The profitability progress is the general direction of BiOasis Technologies' change in net profit over the period of time. It can combine multiple indicators of BiOasis Technologies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut. Bioasis Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange.

BiOasis Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BiOasis Technologies. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BiOasis Technologies position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BiOasis Technologies' important profitability drivers and their relationship over time.

Use BiOasis Technologies in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiOasis Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will appreciate offsetting losses from the drop in the long position's value.

BiOasis Technologies Pair Trading

biOasis Technologies Pair Trading Analysis

The ability to find closely correlated positions to BiOasis Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiOasis Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiOasis Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling biOasis Technologies to buy it.
The correlation of BiOasis Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiOasis Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if biOasis Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiOasis Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BiOasis Technologies position

In addition to having BiOasis Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Petroleum and Natural Gas Thematic Idea Now

Petroleum and Natural Gas
Petroleum and Natural Gas Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Petroleum and Natural Gas theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Petroleum and Natural Gas Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in BiOasis Pink Sheet

To fully project BiOasis Technologies' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of biOasis Technologies at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BiOasis Technologies' income statement, its balance sheet, and the statement of cash flows.
Potential BiOasis Technologies investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although BiOasis Technologies investors may work on each financial statement separately, they are all related. The changes in BiOasis Technologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BiOasis Technologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.